Clinical Trials on MTAP-null Non-Small-Cell Lung Cancer in Australia
Total 541 results
-
AmgenRecruitingMTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid TumorsUnited States, Australia
-
AmgenTerminatedNSCLC | Non-small Cell Lung CancerUnited States, Austria, Australia
-
Trans Tasman Radiation Oncology GroupUnknownNon Small Cell Lung CancerAustralia, New Zealand
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
Uptake Medical Technology, Inc.CompletedLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung CancerAustralia
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon Small Cell Lung Cancer Stage IIIAustralia
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerAustralia, Germany, United States
-
AmgenActavis Inc.CompletedNon-small Cell Lung Cancer MetastaticUnited States, Bulgaria, Australia
-
Radiopharm Theranostics, LtdRecruitingNon Small Cell Lung Cancer | PDL1 Gene MutationAustralia
-
Imugene LimitedActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma LungUnited States, Australia
-
Medical University InnsbruckMerck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerAustria
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
Western Sydney Local Health DistrictUniversity of Western SydneyRecruitingHepatitis | Lung Cancer, Non-small Cell | Lung Cancer Stage IVAustralia
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Uptake Medical Technology, Inc.Not yet recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung CancerAustria, Italy
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
Central European Cooperative Oncology GroupTerminatedNon Small Cell Lung CancerAustria
-
Medical University of ViennaUnknownAdvanced Non-small-cell Lung CancerAustria
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
AstraZenecaCompletedNon-small Cell Lung CancerTurkey, Hong Kong, Australia, Egypt, India, Kuwait, United Arab Emirates
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerAustralia, China, Korea, Republic of, Taiwan
-
Trans Tasman Radiation Oncology GroupCompletedMetastatic Non Small Cell Lung CancerSingapore, Australia
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Medical University of ViennaUnknownNon Small Cell Lung CancerAustria
-
Olivia Newton-John Cancer Research InstituteMerck Sharp & Dohme LLC; ViralyticsActive, not recruiting
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, France, Romania
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompleted
-
BeiGeneTerminatedNon-Small Cell Lung Cancer (NSCLC)China, Australia
-
Eisai Inc.CompletedNon-small Cell Lung CancerCanada, United States, United Kingdom, Australia, Israel, Russian Federation, Czech Republic, France, Greece, Hungary, Poland
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Olivia Newton-John Cancer Research InstituteAustin Health; Merck Healthcare KGaATerminated